Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2026-01-24 @ 9:50 PM
Study NCT ID:
NCT05706506
Status:
COMPLETED
Last Update Posted:
2024-12-13
First Post:
2023-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-23
First Submit QC Date:
None
Study First Post Date:
2023-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-30
Results First Submit QC Date:
None
Results First Post Date:
2024-12-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-10
Last Update Post Date:
2024-12-13
Last Update Post Date Type:
ACTUAL